Dynamic Contrast-Enhanced MR Imaging in Musculoskeletal Tumors

  • June S. Taylor
  • Wilburn E. Reddick
Part of the Medical Radiology book series (MEDRAD)


Soft Tissue Sarcoma Synovial Sarcoma Magn Reson Image Malignant Peripheral Nerve Sheath Tumor Bone Sarcoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abudu A, Davies AM, Pynsent PB, Mangham DC, Tillman RM, Carter SR, Grimer RJ (1999) Tumour volume as a predictor of necrosis after chemotherapy in Ewing's sarcoma. J Bone Joint Surg [Br] 81:317–322CrossRefPubMedGoogle Scholar
  2. Ambros IM, Ambros PF, Strehl S, Kovar H, Gadner H, Salzer-Kuntschik M (1991) MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Cancer 67:1886–1893PubMedGoogle Scholar
  3. Antman K, Crowley J, Balcerzak SP, Kempf RA, Weiss RB; Clamon GH, Baker LH (1998) A Southwest Oncology Group and Cancer and Leukemia Group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in adults with advanced osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma. Cancer 82:1288–1295CrossRefPubMedGoogle Scholar
  4. Aparicio J, Munarriz B, Pastor M, Vera FJ, Castel V, Aparisi F, Montalar J, Badal MD, Gomez-Codina J, Herrnaz C (1998) Long-term followup and prognostic factors in Ewing's sarcoma. A multivariate analysis of 116 patients from a single institution. Oncology 55:20–26CrossRefPubMedGoogle Scholar
  5. Bacci G, Ferrari S, Donati D, Longhi A, Bertoni F, DiFiore M, Comandone A, Cesari M, Campanacci M (1998) Neoadjuvant chemotherapy for osteosarcoma of the extremity in patients in the fourth and fifth decade of life. Oncol Rep 5:1259–1263PubMedGoogle Scholar
  6. Baldini EH, Demetri GD, Fletcher CD, Foran J, Marcus KC, Singer S (1999) Adults with Ewing's sarcoma/primitive neuroectodermal tumor: adverse effect of older age and primary extraosseous disease on outcome. Ann Surg 230:79–86CrossRefPubMedGoogle Scholar
  7. Berger FH, Verstraete KL, Gooding CA, Lang P (2000) MR imaging of musculoskeletal neoplasm. Magn Reson Imaging Clin North Am 8:929–951Google Scholar
  8. Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M, Winkelmann W, Zoubek A, Jurgens H, Winkler K (2002) Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 20:776–790CrossRefPubMedGoogle Scholar
  9. Bloem JL, van der Woude H-J, Geirnaerdt MJA, Hogendoorn PCW, Taminiau AHM, Hermans Jo (1997) Does magnetic resonance imaging make a difference for patients with musculoskeletal sarcoma? Br J Radiol 70:327–337PubMedGoogle Scholar
  10. Bonnerot V, Charpentier A, Frouin F, Kalifa C, Vanel D, Di Paola R (1992) Factor analysis of dynamic magnetic resonance imaging in predicting the response of osteosarcoma to chemotherapy. Invest Radiol 27:847–855PubMedGoogle Scholar
  11. Carsi B, Rock MG (2002) Primary osteosarcoma in adults older than 40 years. Clin Orthop 397:53–61PubMedGoogle Scholar
  12. Cotterill SJ, Ahrens S, Paulussen M, Jurgens HF, Voute PA, Gadner H, Craft AW (2000) Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol 18:3108–3114PubMedGoogle Scholar
  13. Crim JR, Seeger LL, Yao L, Chandnani V, Eckardt JJ (1992) Diagnosis of soft-tissue masses with MR imaging: can benign masses be differentiated from malignant ones? Radiology 185:581–586PubMedGoogle Scholar
  14. Delepine N, Delepine G, Cornille H, Voisin MC, Brun B, Desbois JC (1997) Prognostic factors in patients with localized Ewing's sarcoma: the effect on survival of actual received drug dose intensity and of histologic response to induction therapy. J Chemother 9:352–363PubMedGoogle Scholar
  15. Egmont-Petersen M, Hogendoorn PC, van der Geest RJ, Vrooman HA, van der WH, Janssen JP, Bloem JL, Reiber JH (2000) Detection of areas with viable remnant tumor in postchemotherapy patients with Ewing's sarcoma by dynamic contrast-enhanced MRI using pharmacokinetic modeling. Magn Reson Imaging 18:525–535CrossRefPubMedGoogle Scholar
  16. Eilber FC, Rosen G, Eckardt J, Forscher C, Nelson SD, Selch M, Dorey F, Eilber FR (2001) Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas. J Clin Oncol 19:3203–3209PubMedGoogle Scholar
  17. Erlemann R, Reiser MF, Peters PE, Vasallo P, Nommensen B, Kusnierz-Glaz CR, Ritter J, Roessner A (1989) Musculoskeletal neoplasms: static and dynamic Gd-DTPA-enhanced MR imaging. Radiology 171:767–773PubMedGoogle Scholar
  18. Erlemann R, Sciuk J, Bosse A, Ritter J, Kusnierz-Glaz CR, Peters PE, Wuisman P (1990) Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy. Radiology 175:791–796PubMedGoogle Scholar
  19. Fizazi K, Dohollou N, Blay JY, Guerin S, Le Cesne A, Andre F, Pouillart P, Tursz T, Nguyen BB (1998) Ewing's family of tumors in adults: multivariate analysis of survival and long-term results of multimodality therapy in 182 patients. J Clin Oncol 16:3736–3743PubMedGoogle Scholar
  20. Fletcher BD (1991) Response of osteosarcoma and Ewing sarcoma to chemotherapy: imaging evaluation. AJR 157:825–833PubMedGoogle Scholar
  21. Fletcher BD (1997) Imaging pediatric bone sarcomas: diagnosis and treatment-related issues. Radiol Clin North Am 35:1477–1494PubMedGoogle Scholar
  22. Fletcher CD, Gustafson P, Rydholm A, Willen H, Akerman M (2001) Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification. J Clin Oncol 19:3045–3050PubMedGoogle Scholar
  23. Fletcher BD, Hanna SL, Fairclough DL, Gronemeyer SA (1992) Pediatric musculoskeletal tumors: use of dynamic contrast-enhanced MR imaging to monitor response to chemotherapy. Radiology 184:243–248PubMedGoogle Scholar
  24. Gebhardt MC (2002) What's new in musculoskeletal oncology. J Bone Joint Surg [Am] 84-A:694–701PubMedGoogle Scholar
  25. Geirnaerdt MJA, Bloem JL, van der Woude H-J, Taminiau AHM, Nooy MA, Hogendoorn PCW (1998) Chondroblastic osteosarcoma: characterisation by gadolinium-enhanced MR imaging correlated with histopathology. Skeletal Radiol 27:145–153PubMedGoogle Scholar
  26. Geirnaerdt MJ, Hogendoorn PC, Bloem JL, Taminiau AH, van der Woude HJ (2000) Cartilaginous tumors: fast contrast-enhanced MR imaging. Radiology 214:539–546PubMedGoogle Scholar
  27. Gherlinzoni F, Picci P, Bacci G, Campanacci D (1992) Limb sparing versus amputation in osteosarcoma: correlation between local control, surgical margins, and tumor necrosis — Instituto Rizzoli experience. Ann Oncol 3:23–27Google Scholar
  28. Gherlinzoni F, Bacci G, de Paoli A et al (1999) Adjuvant chemotherapy for high grade soft tissue sarcomas of the extremities in adult patients: results of the Italian randomized trial. Acta Orthop Scand 289:46–47Google Scholar
  29. Glasser DB, Lane JM, Huvos AG, Marcove RC, Rosen G (1992) Survival, prognosis, and therapeutic response in osteogenic sarcoma. Cancer 69:698–708PubMedGoogle Scholar
  30. Glazer HS, Lee JKT, Levitt RG, Heiken JP, Ling D, Totty WG, Balfe DM, Emani B, Wasserman TH, Murphy WA (1985) Radiation fibrosis: differentiation from recurrent tumor by MR imaging. Radiology 156:721–726PubMedGoogle Scholar
  31. Goto A, Takeuchi S, Sugimura K, Maruo T (2002) Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus. Int J Gynecol Cancer 12:354–361CrossRefPubMedGoogle Scholar
  32. Green DM (1985) Diagnosis and management of malignant solid tumors in infants and children. Martinus Nijhoff Publishing, BostonGoogle Scholar
  33. Grier HE (1997) The Ewing family of tumors. Ewing's sarcoma and primitive neuroectodermal tumors. Pediatr Clin North Am 44:991–1004CrossRefPubMedGoogle Scholar
  34. Gullino PM, Grantham FH (1964) The vascular space of growing tumors. Cancer Res 24:1727–1732PubMedGoogle Scholar
  35. Hanna SL, Parham DM, Fairclough DL, Meyer WH, Le AH, Fletcher BD (1992) Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced magnetic resonance mapping. Invest Radiol 27:367–373PubMedGoogle Scholar
  36. Hanna SL, Reddick WE, Parham DM, Gronemeyer SA, Taylor JS, Fletcher BD (1993) Automated pixel-by-pixel mapping of dynamic contrast-enhanced MR images for evaluation of osteosarcoma response to chemotherapy: preliminary results. J Magn Reson Imaging 3:849–853PubMedGoogle Scholar
  37. Hense HW, Ahrens S, Paulussen M, Lehnert M, Jurgens H (1999) Factors associated with tumor volume and primary metastases in Ewing tumors: results from the (EI)CESS studies. Ann Oncol 10:1073–1077CrossRefPubMedGoogle Scholar
  38. Henshaw RM, Priebat DA, Perry DJ, Shmookler BM, Malawer MM (2001) Survival after induction chemotherapy and surgical resection for high-grade soft tissue sarcoma. Is radiation necessary? Ann Surg Oncol 8:484–495PubMedGoogle Scholar
  39. Holscher HC, Bloem JL, Nooy MA, Taminiau AHM, Eulderink F, Hermans J (1990) The value of MR imaging in monitoring the effect of chemotherapy on bone sarcomas. AJR 154:763–769PubMedGoogle Scholar
  40. Holscher HC, Bloem JL, Vanel D, Hermans Jo, Nooy MA, Taminiau AHM, Henry-Amar M (1992) Osteosarcoma: chemotherapy-induced changes at MR imaging. Radiology 182:839–844PubMedGoogle Scholar
  41. Hudson M, Jaffe M, Jaffe N, Ayala AG, Raymond AK, Carrasco CH, Wallace S, Murray JA, Robertson R (1990) Pediatric osteosarcoma: therapeutic strategies, results, and prognostic factors derived from a 10-year experience. J Clin Oncol 8:1988–1997PubMedGoogle Scholar
  42. Huvos AG (1986) Osteogenic sarcoma of bones and soft tissues in older persons. A clinicopathologic analysis of 117 patients older than 60 years. Cancer 57:1442–1449PubMedGoogle Scholar
  43. Huvos AG, Rosen G, Marcove RC (1977) Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy, en bloc resection, and prosthetic bone replacement. Arch Pathol Lab Med 101:14–18PubMedGoogle Scholar
  44. Jain RK (1994) Barriers to drug delivery in solid tumors. Sci Am 271:58–65Google Scholar
  45. Jain RK (1996a) 1995 Whitaker lecture: delivery of molecules, particles, and cells to solid tumors. Ann Biomed Eng 24:457–473PubMedGoogle Scholar
  46. Jain RK (1996b) Delivery of molecular medicine to solid tumors. Science 271:1079–1080PubMedGoogle Scholar
  47. Jain RK (2001) Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nature Med 7:987–989CrossRefPubMedGoogle Scholar
  48. Jenkin RD, Al Fawaz I, Shabanah M, Allam A, Ayas M, Khafaga Y, Memon M, Rifai S, Schultz H, Younge D (2002) Localised Ewing sarcoma/PNET of bone — prognostic factors and international data comparison. Med Pediatr Oncol 39:586–593CrossRefPubMedGoogle Scholar
  49. Kaste SC, Hill A, Conley L, Shidler TJ, Rao BN, Neel MM (2002) Magnetic resonance imaging after incomplete resection of soft tissue sarcoma. Clin Orthop 397:204–211PubMedGoogle Scholar
  50. Kawai A, Sugihara S, Kunisada T, Uchida Y, Inoue H (1997) Imaging assessment of the response of bone tumors to preoperative chemotherapy. Clin Orthop Relat Res 337:216–225CrossRefPubMedGoogle Scholar
  51. Knopp MV, Giesel FL, Marcos H, von Tengg-Kobligk H, Choyke P (2001) Dynamic contrast-enhanced magnetic resonance imaging in oncology. Top Magn Reson Imaging 12:301–308CrossRefPubMedGoogle Scholar
  52. Lawrence JA, Babyn PS, Chan HSL, Thorner PS, Pron GE, Krajbich IJ (1993) Extremity osteosarcoma in childhood: prognostic value of radiologic imaging. Radiology 189:43–47PubMedGoogle Scholar
  53. Link MP, Eilber F (1993) Osteosarcoma. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology, 2nd edn. Lippincott, PhiladelphiaGoogle Scholar
  54. Link MP, Goorin AM, Miser AW, Green AA, Pratt CB, Belasco JB, Pritchard J, Malpas JS, Baker AR, Kirkpatrick JA, Ayala AG, Shuster JJ, Abelson HT, Simone JV, Vietti TJ (1986) The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 314:1600–1606PubMedGoogle Scholar
  55. Ma LD (1999) Magnetic resonance imaging of musculoskeletal tumors: skeletal and soft tissue masses. Curr Probl Diagn Radiol 28:29–62PubMedGoogle Scholar
  56. Ma LD, Frassica FJ, McCarthy EF, Bluemke DA, Zerhouni EA (1997) Benign and malignant musculoskeletal masses: MR imaging differentiation with rim-to-center differential enhancement ratios. Radiology 202:739–744PubMedGoogle Scholar
  57. MacVicar AD, Olliff JF, Pringle J, Pinkerton CR, Husband JE (1992) Ewing sarcoma: MR imaging of chemotherapy-induced changes with histologic correlation. Radiology 184:859–864PubMedGoogle Scholar
  58. Mankin HJ, Mankin CJ, Simon MA (1996) The hazards of the biopsy, revisited. Members of the Musculoskeletal Tumor Society. J Bone Joint Surg [Am] 78:656–663PubMedGoogle Scholar
  59. May DA, Good RB, Smith DK, Parsons TW (1997) MR imaging of musculoskeletal tumors and tumor mimickers with intravenous gadolinium: experience with 242 patients. Skeletal Radiol 26:2–15CrossRefPubMedGoogle Scholar
  60. McCarville MB, Spunt SL, Skapek SX, Pappo AS (2002) Synovial sarcoma in pediatric patients. AJR Am J Roentgenol 179:797–801PubMedGoogle Scholar
  61. Meyers PA, Heller G, Healy J, Huvos AG, Lane JM, Marcove RC, Applewhite A, Vlamis V, Rosen G (1992) Chemotherapy for non-metastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol 10:5–15PubMedGoogle Scholar
  62. Miller SL, Hoffer FA, Reddick WE, Wu S, Glass JO, Gronemeyer SA Haliloglu M, Nikoranov AY, Xiong X, Pappo AS (2001) Tumor volume or dynamic contrast-enhanced MRI for prediction of clinical outcome of Ewing sarcoma family of tumors. Pediatr Radiol 31:518–523CrossRefPubMedGoogle Scholar
  63. Noria S, Davis A, Kandel R, Levesque J, O'sullivan B, Wunder J, Bell R (1996) Residual disease following unplanned excision of soft-tissue sarcoma of an extremity. J Bone Joint Surg [Am] 78:650–655PubMedGoogle Scholar
  64. Ongolo-Zogo P, Thiesse P, Sau J, Desuzinges C, Blay JY, Bonmartin A, Bochu M, Philip T (1999) Assessment of osteosarcoma response to neoadjuvant chemotherapy: comparative usefulness of dynamic gadolinium-enhanced spin-echo magnetic resonance imaging and technetium-99 m skeletal angioscintigraphy. Eur Radiol 9:907–914CrossRefPubMedGoogle Scholar
  65. Onikul E, Fletcher BD, Parham DM, Chen G (1996) Accuracy of MR imaging for estimating intraosseous extent of osteosarcoma. AJR 167:1211–1215PubMedGoogle Scholar
  66. Pan G, Raymond AK, Carrasco CH, Wallace S, Kim EE, Shirkhoda A, Jaffe N, Murray JA, Benjamin RS (1990) Osteosarcoma: MR imaging after preoperative chemotherapy. Radiology 174:517–526PubMedGoogle Scholar
  67. Paulussen M, Ahrens S, Dunst J, Winkelmann W, Exner GU, Kotz R, Amann G, Dockhorn-Dworniczak B, Harms D, Muller-Weihrich S, Welte K, Kornhuber B, Janka-Schaub G, Gobel U, Treuner J, Voute PA, Zoubek A, Gadner H, Jurgens H (2001) Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. J Clin Oncol 19:1818–1829PubMedGoogle Scholar
  68. Peabody TD, Gibbs CP Jr, Simon MA (1998) Evaluation and staging of musculoskeletal neoplasms. J Bone Joint Surg Am 80:1204–1218PubMedGoogle Scholar
  69. Picci P, Bacci G, Campanacci D, Gasparini M, Pilotti S, Cerasoli S, Bertoni F, Guerra A, Capanna R, Albisinni U (1985) Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy: regional mapping of viable and nonviable tumor. Cancer 56:1515–1521PubMedGoogle Scholar
  70. Picci P, Sangiorgi L, Rougraff BT, Neff JR, Casadei R, Campanacci M (1994) Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma. J Clin Oncol 12:2699–2705PubMedGoogle Scholar
  71. Provisor AJ, Ettinger LJ, Nachman JB, Krailo MD, Makley JT, Yunis EJ, Huvos AG, Betcher DL, Baum ES, Kisker CT, Miser JS (1997) Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. J Clin Oncol 15:76–84PubMedGoogle Scholar
  72. Rao BN (1993) Nonrhabdomyosarcoma in children: prognostic factors influencing survival. Semin Surg Oncol 9:524–531PubMedGoogle Scholar
  73. Raymond AK, Chawla SP, Carrasco CH et al (1987) Osteosarcoma chemotherapy effect: a prognostic factor. Semin Diagn Pathol 4:212–236PubMedGoogle Scholar
  74. Reddick WE, Langston JW, Meyer WH, Gronemeyer SA, Steen RG, Chen G, Taylor JS (1994) Discrete signal processing of dynamic contrast-enhanced MR imaging: statistical validation and preliminary clinical application. J Magn Reson Imaging 4:397–404PubMedGoogle Scholar
  75. Reddick WE, Bhargava R, Taylor JS, Meyer WH, Fletcher BD (1996) Dynamic contrast-enhanced MR imaging evaluation of osteosarcoma response to neoadjuvant chemotherapy. J Magn Reson Imaging 5:689–694Google Scholar
  76. Reddick WE, Wang S-C, Xiong X, Glass JO, Wu S, Kaste SC, Pratt CB, Meyer WH, Fletcher BD (2001) Dynamic magnetic resonance imaging of regional contrast access as an additional prognostic factor in pediatric osteosarcoma. Cancer 91:2230–2237CrossRefPubMedGoogle Scholar
  77. Rijpkema M, Kaanders JHAM, Joosten FBM, van der Kogel AJ, Heerschap A (2001) Method for quantitative mapping of dynamic MRI contrast agent uptake in human tumors. J Magn Reson Imaging 14:457–463CrossRefPubMedGoogle Scholar
  78. Rosen G, Marcove RC, Caparros B, Nirenberg A, Kasloff C, Huvos AG (1979) Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery. Cancer 43:2163–2177PubMedGoogle Scholar
  79. Rosen G, Caparros B, Huvos AG et al (1982) Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49:1221–1230PubMedGoogle Scholar
  80. Salzer-Kuntschik M, Delling G, Beron G, Sigmund R (1983) Morphological grades of regression in osteosarcoma after polychemotherapy — study COSS 80. J Cancer Res Clin Oncol 106:21–24CrossRefGoogle Scholar
  81. Sanchez RB, Quinn SF, Walling A, Estrada J, Greenberg H (1990) Musculoskeletal neoplasms after intraarterial chemotherapy: correlation of MR images with pathologic specimens. Radiology 174:237–240PubMedGoogle Scholar
  82. San Julian M, Aquerreta JD, Benito A, Canadell J (1999) Indications for epiphyseal preservation in metaphyseal malignant bone tumors of children: relationship between image methods and histological findings. J Pediatr Orthop 19:543–548CrossRefPubMedGoogle Scholar
  83. Schwickert HC, Stiskal M, Roberts TPL, van Dijke CF, Mann JS, Muhler A, Shames DM, Demsar F, Disston A, Brasch RC (1996) Contrast-enhanced MR imaging assessment of tumor capillary permeability: effect of irradiation on delivery of chemotherapy. Radiology 198:893–898PubMedGoogle Scholar
  84. Shapeero LG, Vanel D (2000) Imaging evaluation of the response of high-grade osteosarcoma and Ewing sarcoma to chemotherapy with emphasis on dynamic contrast-enhanced magnetic resonance imaging. Semin Musculoskelet Radiol 4:137–146CrossRefPubMedGoogle Scholar
  85. Shapeero LG, Vanel D, Verstraete KL, Bloem JL (2002) Fast magnetic resonance imaging with contrast for soft tissue sarcoma viability. Clin Orthop 212–227Google Scholar
  86. Su M-Y, Wang Z, Nalcioglu O (1999) Investigation of longitudinal vascular changes in control and chemotherapy-treated tumors to serve as therapeutic efficacy predictors. J Magn Reson Imaging [Suppl] 9:128–137CrossRefPubMedGoogle Scholar
  87. Su M-Y, Taylor JA, Villarreal LP, Nalcioglu O (2000) Prediction of gene therapy-induced tumor size changes by the vascularity changes measured using dynamic contrast-enhanced MRI. Magn Reson Imaging 18:311–317CrossRefPubMedGoogle Scholar
  88. Tannock IF, Lee CM, Tunggal JK, Cowan DSM, Egorin MJ (2002) Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy. Clin Cancer Res 8:878–884PubMedGoogle Scholar
  89. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HBW, Lee T-Y, Mayr NA, Parker GJM, Port R, Taylor JS, Weisskoff RM (1999) Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusible tracer: standardized quantities and symbols. J Magn Reson Imaging 10:223–232CrossRefPubMedGoogle Scholar
  90. Van der Woude HJ, Bloem JL, Taminiau AHM, Nooy MA, Hogendoorn PCW (1994) Classification of histopathologic changes following chemotherapy in Ewing's sarcoma of bone. Skeletal Radiol 23:501–507PubMedGoogle Scholar
  91. Van der Woude HJ, Bloem JL, Verstraete KL, Taminiau AHM, Nooy MA, Hogendoorn PCW (1995) Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery. AJR 165:593–598PubMedGoogle Scholar
  92. Van der Woude HJ, Bloem JL, Hogendoorn PCW (1998a) Preoperative evaluation and monitoring chemotherapy in patients with high-grade osteogenic and Ewing's sarcoma: review of current imaging modalities. Skeletal Radiol 27:57–71CrossRefPubMedGoogle Scholar
  93. Van der Woude HJ, Bloem JL, Pope TL Jr (1998b) Magnetic resonance imaging of the musculoskeletal system, part 9. Primary tumors. Clin Orthop 347:272–286PubMedGoogle Scholar
  94. Van der Woude HJ, Egmont-Petersen M (2001) Contrast-enhanced magnetic resonance imaging of bone marrow. Semin Musculoskelet Radiol 5:21–33CrossRefPubMedGoogle Scholar
  95. Van Rijswijk CS, Hogendoorn PC, Taminiau AH, Bloem JL (2001) Synovial sarcoma: dynamic contrast-enhanced MR imaging features. Skeletal Radiol 30:25–30CrossRefPubMedGoogle Scholar
  96. Vanel D, Shapeero LG, De Baere T, Gilles R, Tardivon A, Genin J, Guinebretiere JM (1994) MR imaging in the follow-up of malignant and aggressive soft-tissue tumors: results of 511 examinations. Radiology 190:263–268PubMedGoogle Scholar
  97. Verstraete KL, Lang P (2000) Bone and soft tissue tumors: the role of contrast agents for MR imaging. Eur Radiol 34:229–246CrossRefGoogle Scholar
  98. Verstraete KL, de Deene Y, Roels H, Dierick A, Uyttendaele D, Kunnen M (1994a) Benign and malignant musculoskeletal lesions: dynamic contrast-enhanced MR imaging — parametric “first-pass” images depict tissue vascularization and perfusion. Radiology 192:835–843PubMedGoogle Scholar
  99. Verstraete KL, Dierick A, de Deene Y, Uyttendaele D, Vandamme F, Roels H, Kunnen M (1994b) First-pass images of musculoskeletal lesions: a new and useful diagnostic application of dynamic contrast-enhanced MRI. Magn Reson Imaging 12:687–702CrossRefPubMedGoogle Scholar
  100. Verstraete KL, van der Woude H-J, Hogendoorn PCW, de Deene Y, Kunnen M, Bloem JL (1996) Dynamic contrast-enhanced MR imaging of musculoskeletal tumors: basic principles and clinical applications. J Magn Reson Imaging 6:311–321PubMedGoogle Scholar
  101. Verstraete KL, Vanzieleghem B, de Deene Y, Palmans H, de Greef D, Kristoffersen DT, Uyttendaele D, Roels H, Hamers J, Kunnen M (1994c) Static, dynamic and first-pass MR imaging of musculoskeletal lesions using gadodiamide injection. Acta Radiol 35:1–10PubMedGoogle Scholar
  102. Wellings RM, Davies AM, Pynsent PB, Carter SR, Grimer RJ (1994) The value of computed tomographic measurements in osteosarcoma as a predictor of response to adjuvant chemotherapy. Clin Radiol 49:19–23PubMedGoogle Scholar
  103. Wunder JS, Paulian G, Huvos AG, Heller G, Meyers PA, Healey JH (1998) The histologic response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma. J Bone Joint Surg [Am] 80:1020–1033CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • June S. Taylor
    • 1
  • Wilburn E. Reddick
    • 2
  1. 1.Department of RadiologyUniversity of Utah, Utah Center for Advanced Imaging ResearchSalt Lake CityUSA
  2. 2.Department of Diagnostic ImagingSt. Jude Children’s Research HospitalMemphisUSA

Personalised recommendations